Updates are available Correction dated 2020-08-13
Click to view Correction: https://doi.org/10.1038/s41467-020-18036-0
-
Authors
Pavani, Giulia
Laurent, Marine https://orcid.org/0000-0002-7987-9999
Fabiano, Anna https://orcid.org/0000-0002-7604-6967
Cantelli, Erika
Sakkal, Aboud
Corre, Guillaume https://orcid.org/0000-0002-0755-8336
Lenting, Peter J. https://orcid.org/0000-0002-7937-3429
Concordet, Jean-Paul
Toueille, Magali
Miccio, Annarita
Amendola, Mario https://orcid.org/0000-0002-1188-8856
- License Information
-
More Information
Article History
Received: 11 December 2019
Accepted: 6 July 2020
First Online: 29 July 2020
Change Date: 13 August 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing interests
: G.P. and M.A. are the inventors of a patent describing this HSC-based gene therapy platform (Genetically engineered hematopoietic stem cell as a platform for systemic protein expression; EP18305026.9). The remaining authors declare no competing interests.
